Effect of branched-chain amino acids (BCAA) supplementation for patients with non alcoholic fatty liver disease (NAFLD)
Not Applicable
- Conditions
- nonalcoholic fatty liver disease
- Registration Number
- JPRN-UMIN000004972
- Lead Sponsor
- Kagoshima University hospital, Center for Gastroenterology, Gastroenterological Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 15
Inclusion Criteria
Not provided
Exclusion Criteria
1. Patient with viral hepatitis. 2. Alcohol consumer [alcohol intake (ethanol)>=20g/day]. 3. Patient with Hepatocellular carcinoma. 4. Diabetes patients treated with insulin or oral antihyperglycemic drug or uncontrolled patients (HbA1c>=8). 5. Patients who have already been taking BCAA. 6. Subjects who have already been taking amino-acid supplement. 7. Patients with amino-acid metabolism abnormality. 8. Subjects who are judged for non-approved by principal investigator.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To evaluate the liver function and insulin resistance at 12 weeks
- Secondary Outcome Measures
Name Time Method